Hot Flushes
16
1
1
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
92.3%
+5.8% vs benchmark
19%
3 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (16)
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women
Stellate Ganglion Blockade in Post-Menopausal Women
E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)
Stellate Ganglion Block (SGB) For Women for Breast Cancer
Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer
Stellate Ganglion Block to Reduce Hot Flushes
Progesterone for Perimenopausal Night Sweats
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Alternative Treatments for Menopausal Women
Vilazodone for Menopausal Hot Flashes
Menopausal Treatment Using Relaxation Exercises (MaTURE)
Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women
The Role of Vitamin D in Menopause: Relationship to Menopausal Symptoms in Body Composition
Aromatherapy and Yogatherapy for Hot Flashes
A Study of MF101 in Postmenopausal Women